Vanguard Group
PTLA

Vanguard Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-7,004,845
Closed -$126M 4161
2020
Q2
$126M Buy
7,004,845
+89,096
+1% +$1.6M ﹤0.01% 1557
2020
Q1
$49.3M Buy
6,915,749
+170,808
+3% +$1.22M ﹤0.01% 1874
2019
Q4
$161M Buy
6,744,941
+29,824
+0.4% +$712K 0.01% 1502
2019
Q3
$180M Buy
6,715,117
+729,283
+12% +$19.6M 0.01% 1391
2019
Q2
$162M Buy
5,985,834
+151,150
+3% +$4.1M 0.01% 1483
2019
Q1
$202M Buy
5,834,684
+61,122
+1% +$2.12M 0.01% 1332
2018
Q4
$113M Buy
5,773,562
+155,273
+3% +$3.03M 0.01% 1613
2018
Q3
$150M Sell
5,618,289
-49,065
-0.9% -$1.31M 0.01% 1582
2018
Q2
$214M Buy
5,667,354
+208,086
+4% +$7.86M 0.01% 1301
2018
Q1
$178M Buy
5,459,268
+71,078
+1% +$2.32M 0.01% 1358
2017
Q4
$262M Buy
5,388,190
+145,874
+3% +$7.1M 0.01% 1117
2017
Q3
$283M Buy
5,242,316
+637,409
+14% +$34.4M 0.01% 1037
2017
Q2
$259M Sell
4,604,907
-9,907
-0.2% -$556K 0.01% 1061
2017
Q1
$181M Buy
4,614,814
+192,420
+4% +$7.54M 0.01% 1283
2016
Q4
$99.2M Buy
4,422,394
+689,808
+18% +$15.5M 0.01% 1616
2016
Q3
$84.8M Buy
3,732,586
+98,847
+3% +$2.24M 0.01% 1671
2016
Q2
$85.8M Buy
3,633,739
+142,286
+4% +$3.36M 0.01% 1613
2016
Q1
$71.2M Buy
3,491,453
+134,589
+4% +$2.75M ﹤0.01% 1691
2015
Q4
$173M Buy
3,356,864
+290,895
+9% +$15M 0.01% 1104
2015
Q3
$131M Buy
3,065,969
+88,967
+3% +$3.79M 0.01% 1254
2015
Q2
$136M Buy
2,977,002
+543,731
+22% +$24.8M 0.01% 1330
2015
Q1
$92.4M Buy
2,433,271
+312,804
+15% +$11.9M 0.01% 1554
2014
Q4
$60.1M Buy
2,120,467
+457,697
+28% +$13M ﹤0.01% 1735
2014
Q3
$42M Buy
1,662,770
+321,191
+24% +$8.12M ﹤0.01% 1890
2014
Q2
$39.1M Buy
1,341,579
+73,560
+6% +$2.15M ﹤0.01% 1950
2014
Q1
$32.8M Buy
1,268,019
+288,993
+30% +$7.48M ﹤0.01% 2019
2013
Q4
$25.2M Buy
979,026
+525,048
+116% +$13.5M ﹤0.01% 2084
2013
Q3
$12.1M Buy
453,978
+439,607
+3,059% +$11.8M ﹤0.01% 2306
2013
Q2
$353K Buy
+14,371
New +$353K ﹤0.01% 3553